Holocene Advisors
AGL icon

Holocene Advisors’s Agilon Health AGL Stock Holding History

Holocene Advisors’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,269
Closed -$714K – 745
2024
Q3 		$714K Buy
+7,269
New +$939K ﹤0.01% 638
2023
Q4 		– Sell
-8,620
Closed -$3.83M – 685
2023
Q3 		$3.83M Buy
8,620
+7,872
+1,052% +$3.56M 0.02% 436
2023
Q2 		$324K Sell
748
-1,390
-65% -$781K ﹤0.01% 684
2023
Q1 		$1.27M Sell
2,138
-19,344
-90% -$10.8M 0.01% 556
2022
Q4 		$8.67M Buy
21,482
+20,478
+2,040% +$9.6M 0.05% 232
2022
Q3 		$588K Buy
+1,004
New +$601K ﹤0.01% 692
2022
Q1 		– Sell
-5,938
Closed -$4.01M – 859
2021
Q4 		$4.01M Buy
+5,938
New +$3.61M 0.02% 371

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Holocene Advisors's AGL Position: Q4 2024 in Review

Holocene Advisors sold out of Agilon Health (AGL) in Q4 2024, closing a stake of 7,269 shares — an estimated $714K sold.

Holocene Advisors first reported a position in AGL in Q4 2021 and held it in 7 quarters. The position peaked at $8.67M in Q4 2022. 184 funds tracked by Wall St. Rank hold AGL as of Q4 2024.

  • Holocene Advisors reported no remaining Agilon Health position as of Q4 2024 after selling out during the quarter.
  • Holocene Advisors sold 7,269 Agilon Health shares in Q4 2024, an estimated $714K.
  • Holocene Advisors first reported a position in Agilon Health in Q4 2021 and held it in 7 quarters.
  • Holocene Advisors's Agilon Health position peaked at $8.67M in Q4 2022.
  • 184 funds tracked by Wall St. Rank held Agilon Health as of Q4 2024.

Based on Holocene Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.